Disclosures for "MRI hallmarks of LGI1- and CASPR2-antibody encephalitis")
-
The institution of Dr. Kelly has received research support from The Health Research Board / Wellcome Trust.
-
Dr. Grant has nothing to disclose.
-
Andrew Murchison has nothing to disclose.
-
-
The institution of Ms. Binks has received research support from Wellcome Trust. The institution of Ms. Binks has received research support from PetSavers. The institution of Ms. Binks has received research support from PetPlan. Ms. Binks has received intellectual property interests from a discovery or technology relating to health care. Ms. Binks has a non-compensated relationship as a Speaker with Encephalitis Society UK that is relevant to AAN interests or activities.
-
-
Dr. Sheerin has received personal compensation in the range of $5,000-$9,999 for serving as an officer or member of the Board of Directors for Indigo Silver Neuroimaging Ltd.
-
Dr. Irani has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Immunovant, UCB, Cerebral therapeutics, Roche and Janssen. Dr. Irani has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Irani has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Irani has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Brain. Dr. Irani has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for LLPs. Dr. Irani has received intellectual property interests from a discovery or technology relating to health care. Dr. Irani has received intellectual property interests from a discovery or technology relating to health care. Dr. Irani has received intellectual property interests from a discovery or technology relating to health care.